HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Mylan N.V. (MYL)
15.69  0.09  (0.58%) 10-25 06:18
Open: 15.75 High: 15.8
Pre.close: 15.6 Low: 15.44
Volume: 2,598,019 Ave vol: 4,787,760
52w High: 23.11 52w Low: 12.75
MA(50): 15.27 MA(200): 16.074
EPS: 0.524 P/E Ratio: 29.94
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers General Specialty & Generic
Website: https://www.mylan.com
Market Cap (M): 8,111
Shares Out (M): 517
Mylan NV is a pharmaceutical healthcare company. The company is headquartered in Hatfield, Hertfordshire and currently employs 35,000 full-time employees. The firm develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. The company operates through three segments on a geographic basis, North America, Europe and Rest of World. The firm's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.
Technical analysis
Overall: Outperform
MA: Bearish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 18.78 Target 2: 21.94
Resist 1: 16.08 Resist 2: 18.78
Support 1: 14.81 Support 2: 14.02
Company key metrics
Revenue per Share: 22.2662
Net Income per Share: 0.0325
Cash per Share: 0.9208
Book Value per Share: 23.0083
Price to Sales: 0.9845
Price to Book Value: 0.9527
Earnings Yield: 0.0015
Dividend Yield: 0
Debt to Equity: 1.6301
Debt to Assets: 0.6198
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Outperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.